Latest Breaking News On - Development of medicines - Page 1 : comparemela.com

Innovent Announces the New Drug Application of IBI311 (IGF-1R antibody) has been Accepted by the NMPA of China for Thyroid Eye Disease

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

United statesAlia teprotumumabEli lillyInnovent biologicsAdimab incyteGroup of oculoplasticGroup of thyroid diseasesMd anderson cancer centerClinical development of innoventAmerican thyroid societyPrnewswire innovent biologics incChinese ophthalmology branchChinese academy of engineeringChinese medical associationAmerican thyroid associationDevelopment of medicines

Innovent Announces Primary Endpoint Met in the Phase 3 Clinical Trial (RESTORE-1) of IBI311 (Anti-IGF-1R Antibody) in Treating Thyroid Eye Disease and Plans to Submit NDA to the NMPA

ROCKVILLIE, MD. and SUZHOU, China, Feb. 20, 2024 /PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company

United statesAdimab incyteAlia teprotumumabInnovent biologicsEli lillyInnovent biologics incGroup of oculoplasticEuropean group on grave orbitopathyAmerican thyroid societyChinese ophthalmology branchEuropean thyroid societyNational drug administrationClinical development of innoventEuropean thyroid associationChinese medical associationEuropean group on grave

Innovent Announces Primary Endpoint Met In The Phase 3 Clinical Trial (RESTORE-1) Of IBI311 (Anti-IGF-1R Antibody) In Treating Thyroid Eye Disease And

Innovent Announces Primary Endpoint Met In The Phase 3 Clinical Trial (RESTORE-1) Of IBI311 (Anti-IGF-1R Antibody) In Treating Thyroid Eye Disease And
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesEli lillyInnovent biologicsAdimab incyteAlia teprotumumabChinese ophthalmology branchPrnewswire innovent biologics incEuropean group on graveChinese endocrinology branchGroup of oculoplasticDevelopment of medicinesClinical development of innoventEuropean thyroid associationEuropean thyroid societyEuropean group on grave orbitopathyMd anderson cancer center

Cuba´s NeuroEPO drug shows positive results to treat Alzheimer s

Havana, Dec 13 (Prensa Latina) 54% of patients treated for Alzheimer's disease during clinical trials with the new Cuban drug NeuroEPO has shown significant clinical results, Cuban scientists assured.

Tania crombetClinical researchDevelopment of medicinesMolecular immunologyResearch director tania crombet

Russia and Cuba join efforts to fight cancer

Moscow, Dec 2 (Prensa Latina) The representation of BioCubaFarma in Russia and the Russian company Alphanil signed a co-development agreement in this capital to expand the research of an innovative product against cancer.

Samarskaya oblastDimitri chelovskyAdolfo castilloIndustries biocubafarmaDevelopment of medicinesCuban group of biotechnologicalSkolkovo innovation centerMolecular immunology centerCuban groupPharmaceutical industriesPrensa latinaHavana based molecular immunology centerGeneral director